Back to results
CompletedPhase 1

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease

NCT02267434

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Medical University Innsbruck, Department of Neurology

Innsbruck, Austria

+1 additional location

View on ClinicalTrials.gov
Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease — TrialFind